Clinical Trials Directory

Trials / Completed

CompletedNCT03780556

Lornoxicam With Low Dose Ketamine Versus Pethidine to Control Pain of Acute Renal Colic

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Accepted

Summary

Patients with acute renal colic divided into 2 groups. Group L administered ornoxicam and Group P administered pethidine and VAS was recorded for both groups.

Detailed description

Prospective, randomized, double blind clinical study including 120 patients with acute renal pain admitted in emergency department. They were randomly assigned to one of two groups using a computer-generated table. Group L received lornoxicam 8 mg IV plus 0.15 mg.kg-1 ketamine and Group P received pethidine 50 mg IV. Parameters were observed at baseline and after 0, 15, 30, 45 and 1 hour of drug treatment. The efficacy of the drug was measured by observing: patient rated pain, time to pain relief, rate of pain recurrence, the need for rescue analgesia, adverse events and functional status.

Conditions

Interventions

TypeNameDescription
DRUGLornoxicam and mepridinecompare the effect of each to control pain

Timeline

Start date
2016-01-02
Primary completion
2017-07-01
Completion
2018-05-01
First posted
2018-12-19
Last updated
2018-12-21

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03780556. Inclusion in this directory is not an endorsement.